https://media.gm.com/media/us/en/gm/news.detail.html/content/Pages/news/us/en/2021/jul/0715-ultium.html
Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations
Teva Pharmaceutical Industries Ltd’s (NYSE:TEVA) Q4 sales reached $3.88 billion, shrinking 5% Y/Y, missing the consensus of $3.93 billion. The…